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ProhibitinWe report proteomic analyses that establish the effect of cytoplasmic prion [PSI+] on the protein
complement of yeast mitochondria. A set of 44 yeast mitochondrial proteins whose levels were affected by
[PSI+] was identiﬁed by two methods of gel-free and label-free differential proteomics. From this set we
focused on prohibitins, Phb1 and Phb2, and the mitochondrially synthesized Cox2 subunit of cytochrome
oxidase. By immunoblotting we conﬁrmed the decreased level of Cox2 and reduced mitochondrial
localization of the prohibitins in [PSI+] cells, which both became partially restored by [PSI+] curing. The
presence of the [PSI+] prion also caused premature fragmentation of mitochondria, a phenomenon linked to
prohibitin depletion in mammalian cells. By fractionation of cellular extracts we demonstrated a [PSI+]-
dependent increase of the proportion of prohibitins in the high molecular weight fraction of aggregated
proteins. We propose that the presence of the yeast prion causes newly synthesized prohibitins to aggregate
in the cytosol, and therefore reduces their levels in mitochondria, which in turn reduces the stability of Cox2
and possibly of other proteins, not investigated here in detail.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Prions are a unique class of infectious agents whose infectivity relies
solely on protein. In mammals, they cause fatal neurodegenerative
diseases such as Creutzfeldt–Jacob disease in man, ovine scrapie and
bovine spongiform encephalopathy. All these diseases are related to the
PrP protein whose conformationally altered form (PrPSc) is able to
convert the normal host-encoded protein (PrPC) into an altered prion
form. While only one prion protein is known in mammals, the
mammalian prions appear to represent just part of a much wider
phenomenon, also being found in lower eukaryotes. In contrast to
mammalian prions, those of lower eukaryotes cause non-chromosomal
inheritance of phenotypic traits (reviewed in [1,2]). From a structural
point of viewprion proteins, and also yeast prions, possess the ability for
spontaneous assembly in an autocatalytic process into amyloid [3].
Amyloid-type protein aggregates are characterized by the so-called
“cross-beta” alignment of monomeric units, and yeast prions are no
exception [4–6]. Yeast prions may be used as a convenient model forBiophysics, Polish Academy of
+48 22 592 1312; fax: +48 22
ll rights reserved.elucidation of the factors interacting with human prions and other
amyloids.
The yeast prion [PSI+] is a self-perpetuating conformation of the
translation termination factor Sup35 (eRF3) (for a review, see [7]).
Sup35 forms a complexwith Sup45/eRF1 that is involved in recognizing
termination codons and releasing the translation product from the
ribosome [8,9]. The prion state of Sup35 can be propagated for many
cellular generations in a stable way. This may be observed as the
nonsense suppressor phenotype, [PSI+], which reﬂects the reduced
function of Sup35 due to aggregation of its prion form. It is noteworthy
that [PSI+] can also induce read-through of stop codons at the end of
open reading frames of yeastwild typegenes,which could be the reason
for the variety of weak phenotypes manifested by [PSI+] strains [10].
The study of the yeast prion [PSI+] resulted in the ﬁrst evidence
connecting prions with a cellular stress defense system [11]. Various
chaperones can either promote prion propagation and generation
or eliminate it from the cell. [PSI+] and other yeast prions, [URE3] and
[PIN+], are maintained only in the presence of the chaperone Hsp104
(for a review see [1]). It has been shown that increasing or decreasing
the level of Hsp104 results in the loss of [PSI+]. The stress-inducible Ssa
proteins generally help prions to propagate, while constitutively
expressed proteins of the Ssb family are prion antagonists [12–14].
Hsp40 co-chaperones, Ydj1 and Sis1, as well as Sse1, a nucleotide
exchange factor for Hsp70, exhibit various effects on yeast prions
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papers proved a physical interaction between Sup35 and Hsp104
in vitro and suggest its existence in vivo. Sup35, preferentially in the
[PSI+] state interacts also directly with some other chaperones [17–19].
Our previous work indicated a connection between the yeast prion
[PSI+] and mitochondria. Although the [PSI+] wild type strain exhibited
no difference in respiration competence compared to the corresponding
[psi−], in combination with a mutant Nam9-1 protein of the mitochon-
drial ribosome [PSI+] caused a lack of respiration [20]. This effect of [PSI+]
in the nam9-1 mutant correlated with decreased levels of the
mitochondrially encoded Cox2 and other subunits of cytochrome
oxidase, a hetero-oligomeric protein complex located in the inner
mitochondrial membrane. The respiratory deﬁciency in the nam9-1
mutant was cured by overproduction or inactivation of Hsp104, exactly
the same conditions that eliminate [PSI+]. Another prion, [PIN+], which
often coexists with [PSI+], was not known during the time of this study
and [PIN] status of the nam9-1 mutant was not determined. However
[PIN+] is not cured by overproduced Hsp104, therefore [PIN+] could be
excluded as a potential reason of respiratory deﬁciency in nam9-1. We
then considered how the presence of [PSI+] aggregates interferes with
mitochondrial function. Since it had been reported that proteins can
become trapped in [PSI+] aggregates [21], we expected that recruitment
of proteins interacting with the mitochondrial translation machinery by
[PSI+] aggregates might account for the respiratory deﬁciency in the
presence of Nam9-1. Itwas also conceivable that [PSI+] aggregatesmight
change the level of cytosolic chaperones required for the translocation of
proteins to mitochondria, which in turn might alter the relative level of
one or more components of the mitochondrial translation system.
Finally, one could expect that [PSI+]-induced stop codon readthrough
generates one or more novel mitochondrial proteins bearing an extra C-
terminal domain and causing respiratory deﬁciency in combinationwith
Nam9-1. In this context it was of interest to perform a quantitative
comparison of mitochondrial proteins in isogenic [PSI+] and [psi−]
strains.
The mitochondrial proteome, being a relatively small, but still
complicated protein network, has already been studied in considerable
detail. Several reports describing the set of mitochondrial proteins from
yeast andmammals have been published [22–35]. In addition, different
genomic approaches have been integrated to deﬁne a complete protein
repertoire of the organelle using yeast mitochondria as a model [24].
Moreover, a comprehensive network of protein interactions in a
mitochondrial system, as part of the yeast interactome, has been built.
This map of the interrelationships among mitochondrial proteins
greatly facilitates the interpretation of the results of global analyses of
the yeast mitochondrial proteome upon perturbation [36].
Here, global proteomic analysis was applied to search for the
differences in the levels of mitochondrial proteins in two isogenic
yeast [psi−] and [PSI+] strains. This analysis identiﬁed 44 candidate
proteins ofwhich the levelswere signiﬁcantly changed. The list includes,
for instance, Cox2 protein, which was found in a previous study to be
downregulated in the presence of [PSI+]. Two other proteins from the
list, prohibitinsPhb1andPhb2, immediateneighbors of Cox2 in the yeast
mitochondrial interactome net, were selected for further analysis. Their
downregulation in the presence of the prion [PSI+] and their regulation
by Hsp104 level was conﬁrmed by Western blot analysis. Furthermore,
fractionation of yeast cell lysates demonstrated [PSI+]-dependent
enrichment of prohibitins in the aggregated protein fraction. Our results
indicate that depletion of prohibitins can provide the rationale for the
mitochondrial functional defects observed earlier in [PSI+] yeast cells.
2. Materials and methods
2.1. Yeast strains and growth conditions
Saccharomyces cerevisiae strain GT197 (MATα ade1-14 trp1-Δ ura3-
52 leu2-3,112 lys2 his3), referred to as [psi−] and the isogenic [PSI+]strainGT81-1D [37]were used throughout this study. In the experiment
shown in Fig. 2B derivatives of MB43-nam9-1 (MATa ura3 his3, his4C
nam9-1 [PSI+]) [20] were used. In order to prevent glucose repression
yeast cells were grown in YPE medium (1% yeast extract, 2%
bactopeptone, 2% ethanol) or in low-glucosemedium (1% yeast extract,
2% bactopeptone, 0.5% glucose). Cultures were harvested at an optical
density of 600 nm (OD600) of 1.5 to 1.7, which corresponded, in the case
of the low-glucose medium, to a point of glucose exhaustion, as
determined with Glucostix (Bayer).
To assess mitochondria by ﬂuorescence, GT197 [psi−] and the
isogenic [PSI+] GT81-1D strains were transformedwith pYX323-mtGFP
plasmid (2 µ, TRP1) encoding green ﬂorescence protein (GFP) with a
mitochondrial localization sequence [38]. Transformantswere grown in
minimal SC-trp medium (0.67% yeast nitrogen base, 2% glucose)
supplemented with all amino acids except tryptophan. Cells were
harvested at OD600=1.2. Neither [psi−] nor the [PSI+] strain has a
tendency to become rho−.
2.2. Isolation of mitochondria
Isolation of mitochondria was accomplished by differential centri-
fugation according to [39]. Crude mitochondria (protein concentration
of 5 mg/ml) were suspended in SEM buffer (250 mM sucrose, 1 mM
EDTA, 10 mM MOPS, pH 7.2) ensuring proper osmotic pressure for
maintenance of organelle integrity and prevention of its decomposition.
The suspension of crude mitochondria was loaded onto a three-step
sucrose gradient composed of 1.5 ml 60%, 4 ml 32%, 1.5 ml 23% and
1.5 ml 15% sucrose in EM-buffer (1 mM EDTA, 10 mM MOPS, pH 7.2)
and centrifuged for 1 h at 134000×g, yielding highly puremitochondria
at the 60/32% sucrose interface. The sucrose gradient step was per-
formed twice.
2.3. Differential proteomic experiments
Two methods were used for identiﬁcation of proteins differentially
populated in the two [psi−] and [PSI+] strains analyzed. Their detailed
description is given in the Supportingmaterials andmethods section. In
brief, in the ﬁrst method, further referred to as FTICR, the protein ratios
were measured by comparing the amplitudes of their corresponding
peptide signals in the MS spectra obtained from a mitochondrial
proteome tryptic peptide mixture in LC–MS experiments using an LTQ
FTICR (Thermo) mass spectrometer. In the second method, further
referred to as WPES, a commercially available Waters Protein
Expression System, designed to carry out differential proteomic ex-
periments, was used to extract differentially populated proteins. The
ﬁnal selection of mitochondrial proteins sensitive to the presence of the
cytoplasmic prion [PSI+]wasbasedon statistical validationof the results
of replicate experiments.
2.4. Peptide isoelectrofocusing
Peptide isoelectrofocusing was carried out as described previously
[40] with a minor change to the protocol, as follows: 100 µg of pro-
teins in 100 µl of 100 mM ammonium bicarbonate pH 8.5 was dena-
tured for 5 min at 98 °C and cooled on ice. Ten microliters of modiﬁed
sequencing grade trypsin (Promega), 100 ng/μl, was added and the
samples were incubated o/n at 37 °C. The protein digest was dried in
a speed-vac and suspended in 340 µl of sample buffer (7 M urea, 2 M
thiourea, 2% Chaps, 0.5% β-mercaptoethanol, 0.006% IPG buffer pH
3.5–5.0 (Amersham). To remove insoluble material centrifugation at
15 000×g was performed for 15 min and supernatant was used for
overnight passive rehydration of an 18 cm strip of the gel (pH 3.5–4.5)
in IPG buffer. IEF was performed on a Multiphor II electrophoresis
system (Amersham) using a three-step gradient program as follows:
step 1: 500 V, 2 mA, 2 W, 1 h; step 2: 1000 V, 2 mA, 2 W, 2 h; step 3:
3500 V, 2 mA, 4 W, 45 h.
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eluted three times with 100 µl 0.1% TFA, 2% acetonitrile. Pooled
fractions were ﬁltered through a 50 kDa cut-off cellulose membrane
(Millipore) and concentrated on a speed-vac. Qualitative analysis
(protein identiﬁcation) was carried out using merged datasets
obtained for each of the ten pieces of the IPG strip, as described in
Supporting materials section S1 for the LTQ FTICR qualitative analysis
step.
2.5. Fractionation of yeast cell lysates
For the experiment presented in Fig. 2C, total cellular protein was
extracted by alkaline lysis as described previously [41]. For the
fractionation of aggregates (experiment presented in Fig. 3), cells
were lysed by vortexing with glass beads in buffer A (25 mM Tris–HCl,
pH 7.5, 50 mMKCl, 10 mMMgCl2, 1 mM EDTA, 2% glycerol) along with
1 mM PMSF, 2 µg/ml aprotinin, 1 µg/ml pepstatin A, 0.5 µg/ml
leupeptin, 2.5 µg/ml anti-pain, 0.5 µg/ml TLCK, 0.5 µg/ml TPCK,
0.1 mM benzamidine and 0.1 mM sodium metabisulﬁte. Cell debris
and mitochondria were removed by centrifugation at 15000×g for
10 min. Obtained supernatants were treatedwith RNase A (400 µg/ml)
to disrupt polyribosomes. Extracts were then subjected to centrifuga-
tion through a sucrose cushion (1 ml of 30% sucrose in buffer A) in an
SW50 rotor at 45000rpm for 30 min at 4 °C. The resulting supernatants,
intermediate fractions and pellets were analyzed by Western blotting.
2.6. Western blotting
For immunoblotting, protein extracts were separated by SDS-PAGE
gels and transferred electrophoretically onto a nitrocellulose mem-
brane (Millipore). After immunodecoration with the desired primary
antibody, membranes were incubated with anti-rabbit or anti-mouse
horseradish peroxidase-conjugated secondary antibody. Reaction
with Immobilon Western Chemiluminescent HRP Substrate (Milli-
pore) was performed according to the manufacturer's instructions
and light emitted was subsequently captured on X-ray ﬁlm (Amer-
sham). Films were quantiﬁed using ImageQuant (GE Healthcare Life
Sciences) with local average background correction.
2.7. Confocal microscopy
Cells were washed with water, plated on microscope glass slides
and subjected to confocal laser scanning microscopy. An Eclipse
TE2000-E microscope (Nikon), equipped with a Plan Apo 60× oil
objective was used. mtGFP was excited with an Argon-Ion laser at
488 nm, and emission was detected at 515/30 nm. Images were
collected with the EZ-C1 Confocal v. 3.6 program (Nikon) and then
processed with EZ-C1 Viewer v. 3.6 (Nikon) and Adobe Photoshop 8.0.
3. Results
3.1. Analysis of mitochondrial proteome
Mitochondria were isolated from S. cerevisiae prion-free strain
GT197 referred to as [psi−] and the isogenic strain GT81-1D containing
[PSI+] referred to as [PSI+]. Both [psi−] and [PSI+] strains are respiratory
competent and mitochondria were isolated using a standard fraction-
ation procedure. The identiﬁcation of mitochondrial proteins derived
from [PSI+] and [psi−] strains was carried out by several rounds of LC–
MS–MS/MS (Liquid Chromatography coupled toMass Spectrometry in
data-dependent switch to fragmentation mode) experiments using an
LTQ FTICR spectrometer, as described in the Supporting materials and
methods section. The obtained list of 1275 mitochondrial proteins was
compared with the mitochondrial proteome characterized previously
by other authors [22–28], (Supporting materials Table S1). In all, 972
(76%) proteins were indicated as mitochondrial in earlier either MS-based or “in silico” studies (Supporting materials Fig. S1). We identiﬁed
34 mitochondrial proteins that are present in the MREF mitochondrial
database [42] although, to our knowledge, they have not been identiﬁed
previously by MS-based studies on the S. cerevisiae mitochondrial
proteome [22–27], Prokish-unpublished dataset, [28] (Supporting
materials Table S2). Our list of proteins contains representatives of 45
out of the 46 major functional modules of the yeast mitochondrial
interactome constructed by Perocchi et al. [36] (Supporting materials
Fig. S2 and Table S3).
Similarly to other proteomic studies, the number of detected proteins
was higher than the number of proteins in the accepted mitochondrial
reference set. Two factors may explain this apparent inconsistency. First,
it is possible that themitochondrial reference set is not yet complete and
that thedetectedproteinsarenewmitochondrialproteins, or second, our
preparation procedure did not fully eliminate non-mitochondrial
proteins. It has to be noted, however, that the main aim of our
experiment was to identify differential proteins between [PSI+] and
[psi−] strains. Therefore the possible presence of non-mitochondrial
proteins does not compromise the validity of our results.
In conclusion, our identiﬁcation of mitochondrial proteins in [PSI+]
and [psi−] strains, proved to be of comparable quality to previous protein
identiﬁcation efforts. Thus we can state that the set of mitochondrial
proteins considered in the differential analysis is reasonably complete
and representative.
3.2. Prohibitins and Cox2 among proteins identiﬁed by differential
proteomics of the mitochondria of [PSI+] and [psi−] strains
To obtain a list of proteins of which the levels are affected by the
presence of prion [PSI+], two independent methods of differential
proteomics, named FTICR andWPES, were used and each was repeated
three times (see the Supporting materials and methods section for
details of the methods, the statistical analysis and hit acceptance
criteria). Fig. 1 shows the comparisonof protein level as the [PSI+]/[psi−]
ratios. Forty-one of these proteins showed the same direction of
expression changes in both experiments (Supporting materials Table
S4). This fairly large number of detected differential proteins indicates
that the presence of prion [PSI+] in the yeast cytoplasm induces a
complex response in mitochondria.
[PSI+]-dependent proteins identiﬁed in our experiment belong to
several annotation categories. [PSI+] mitochondria showed decreased
levels of several subunits of respiratory complexes, such as Cox2, Atp1,
Atp2, Atp3 and Sdh1. Therewere also decreased levels of some enzymes
of isocitratemetabolism. In additionweobservedmarked changes in the
levels of some chaperones and receptors involved in mitochondrial
protein import, such as Tom40, Tim13 and Ssc1. The identiﬁcation of
these proteins as affected by [PSI+] links the prion with the reor-
ganization of the mitochondrial import apparatus. Interestingly, both
prohibitins Phb1 and Phb2 were also downregulated in the [PSI+]
mitochondria. Phb1 and Phb2 prohibitins act as membrane-bound
chaperones involved in the stabilization of mitochondrial translation
products including Cox2 [43–45]. Because of this relation, Cox2 and
prohibitins are immediate neighbors in the yeast mitochondrial
interactome [46] (Supporting materials Fig. S3). Moreover, Cox2 is
known to be involved in prion-dependent phenomena in yeast [20].
Encouraged by the known functional links between Cox2, Phb1 and
Phb2, we focused our attention on these three proteins.
Two independent proteomic methods showed that Cox2 and the
two prohibitins, Phb1 and Phb2, are less abundant in mitochondria in
[PSI+] cells. In the [PSI+] strain the Cox2 level was decreased over 3.5
fold (p=0.0048). The [PSI+]/[psi−] ratio for Cox2was estimated on the
basis of eleven peptides in FTICR and eight in the WPES experiment,
respectively. Phb1 was decreased 1.9 fold (p=0.058) as estimated on
the basis of seven peptides in FTICR and ten in WPES. For Phb2 17
peptides in FTICR, and 11 inWPESwere used for ratio calculation giving
a 1.3 fold decrease in [PSI+] cells (p=0.11). The signal amplitude values
Fig. 1. Proteins showing [PSI+]-dependent abundance in yeast mitochondria. The [PSI+]/[psi−] ratios of differential proteins (log scale) were detected by the two independent
differential proteomic methods: FTICR and WPES (see text). The ratio obtained for each protein with the FTICR method is shown as a red bar and with WPES as a black bar, and the
corresponding protein name abbreviation is marked along the upper horizontal axis. For the majority of proteins (41 out of 44) both methods gave the same direction of change i.e.
up- or downregulation, however, the degree of change was often substantially different. Note the Phb1, Phb2 and Cox2 proteins (marked in green) downregulated in [PSI+], as
described in detail in the text.
Fig. 2. [PSI+] decreases amounts of Phb1, Phb2 and Cox2 in mitochondria. Western blot
analysis of Cox2, Phb1 and Phb2 levels inmitochondrial (A, B) and total protein extracts
(C)was prepared by alkaline lysis. Proteinswere isolated from isogenic [psi−] and [PSI+]
strains GT197 and GT81-1D (A, C) or isogenic derivatives of MB43-nam9-1 strain cured
from [PSI+] by deletion [Δ] or overexpression [↑] of the HSP104 gene (B). The levels of
Hsp104 were determined in the total extracts. Mitochondrial malate dehydrogenase
(Mdh1) was used as a loading control.
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materials Fig. S4.
3.3. Reduced levels of Cox2 and prohibitins in [PSI+] mitochondria
detected by immunoblotting
Toprovide independent conﬁrmationof theMSdifferential analyses,
mitochondria isolated from [psi−] and [PSI+] cells were analyzed by
Western blotting with speciﬁc antibodies. The results (Fig. 2A)
reproducibly conﬁrm that the presence of [PSI+] reduces the levels of
mitochondrial Cox2, Phb1 and Phb2.We next investigated whether the
amount ofmitochondrial prohibitinswas affectedby curingof cells from
[PSI+]. Yeast may be cured from the [PSI+] prion by overexpression or
deletion of the gene encoding the Hsp104 chaperone [1,2,11]. We took
advantage of two observations: ﬁrst, that [PSI+] curing by Hsp104
stabilized Cox2 in the MB43-nam9-1 strain [20] and second, that
prohibitins are known to stabilizemitochondrially synthesizedproteins,
including Cox2 [43–45]. Thus we considered the possibility that [PSI+]
curing may increase the levels of prohibitins in mitochondria and that
this effect is a prerequisite for Cox2 stabilization. Indeed, the Western
blot analysis of the mitochondria (Fig. 2B) showed that deletion or
overexpression of the HSP104 gene in [PSI+] MB43-nam9-1 cells
resulted in an increase in Phb1 and Phb2 levels. These results clearly
indicate a link between curing of the [PSI+] prion and the levels of
prohibitins and Cox2 in mitochondria.
For quantiﬁcation, the intensities of bands were measured using
nuclear-encoded mitochondrial malate dehydrogenase Mdh1 as an
internal control. The results of MS and Western analyses comparing
the effect of [PSI+] were consistent, even in cells of different genetic
background (Table 1). Cox2 is a mitochondrially synthesized protein,
the stability of which is known to be prion-dependent [20], and our
work conﬁrmed this. In contrast, prohibitins are synthesized in the
cytoplasm and then imported tomitochondria. The observed decrease
in the amount of mitochondrial prohibitins might result from their
lower synthesis in [PSI+] cells. Interestingly, Western blot analysis of
total yeast extracts shows a decreased amount of Cox2 in the [PSI+]
strain, but does not reveal differences between the levels of
prohibitins in the [psi−] and [PSI+] strains (Fig. 2C). This suggests
that the observed depletion of mitochondrial prohibitins was due to
Table 1




Western blots Differential proteomics
1 2 3 WPES FTICR
Phb1 0.68 0.52 0.65 0.60 0.53
Phb2 0.34 0.44 0.40 0.71 0.75
Cox2 0.41 nd nd 0.41 0.28
[PSI+]/[psi−] protein ratios were measured by densitometry of Western blots and by
differential proteomics.
In order to determine the relative amount of proteins in [PSI+] and [psi−] strains by
immunoblotting, the amount of each protein present in [PSI+], corrected by the loading
control, was set to 1. Column 1 represents the quantiﬁed results of immunoblotting
analysis of Phb1, Phb2 and Cox2 in mitochondria from [PSI+] and [psi−] strains GT197
and GT81-1D (Fig. 2A). Columns 2 and 3 show the quantiﬁed results of the
immunoblotting analysis of Phb1 and Phb2 in mitochondria from different pairs of
isogenic [PSI+] and [psi−] strains in the genetic background of MB43-nam9-1 [PSI+] and
its [psi−] derivative derived by deletion (column 2) or overexpression (column 3) of the
gene encoding Hsp104 chaperone (Fig. 2C). The complex effect of Hsp104 on Cox2
levels in [PSI+] cells was determined previously [20].
[PSI+]/[psi−] protein ratios for Phb1, Phb2 and Cox2 were determined independently
by using two MS-based methods, FTICR and WPES, as described in the text and
presented in the Supporting materials (Table S4, Fig. S4). Of note is the consistency
between the numbers obtained by each method.
Fig. 3. Abundance of prohibitins in cellular aggregates depends on the [PSI] state of the
cell. Lysates of [psi−] and [PSI+] strains (GT197 and GT81-1D) were prepared as
described in the Materials and methods and were fractionated by centrifugation
through a sucrose cushion. The distribution of Phb1, Phb2 and Sup35 between the
supernatant soluble fraction, sucrose layer and high molecular structures in the pellet
was determined by immunoblotting. To conﬁrm that other mitochondrial proteins are
not present in the pellet, the blot was also decorated with an antibody speciﬁc for
aconitase Aco1, the protein imported to mitochondria from the cytoplasm. The gel was
loaded using 20 µg of protein per lane for the supernatant and sucrose fractions and
5 µg of protein per lane for the pellet fraction.
Fig. 4. Fragmentation of mitochondria in prohibitin-deﬁcient [PSI+] cells. [psi−] and
[PSI+] strains (GT197 and GT81-1D) were transformed with pYX323-mtGFP plasmid
encoding green ﬂuorescence protein (GFP) with a mitochondrial localization
sequence and analyzed by confocal laser scanning microscopy. Reconstruction of
the mitochondrial network was done from about ten confocal sections with intervals
of 0.5 µm and 1024×1024 resolution. The images presented are representative for
[psi−] and [PSI+] cells. More than 400 cells were scored per experiment. The per-
centage of cells with tubular mitochondria is indicated.
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prion.
3.4. [PSI+] causes enrichment of prohibitins in the cellular aggregate
fraction
[PSI+] is the prion conformation of the Sup35protein, a cytoplasmic
translation termination factor. [PSI+] affected the levels of mitochon-
drial prohibitins but not their total amount in the yeast cell (Fig. 2),
suggesting a defect in intracellular distribution. This might be due to a
physical interaction of prohibitins with Sup35 aggregates occurring in
the cytoplasm and affecting their import to mitochondria.
It has previously been shown that Sup35 forms high-molecular-
weight aggregates in [PSI+] cells, co-sedimenting with the heavy
polyribosomal fraction andeven larger structures [47]. Thus distribution
of prohibitins between the soluble and aggregated fractions could be
inﬂuenced by the [PSI] status of the cells. To check this, extracts of
isogenic [psi−] and [PSI+] strainswereprepared using the clarifying spin
to eliminate the remaining mitochondria (see Materials and methods).
Extracts were fractionated by centrifugation through a sucrose cushion,
and the fractions were analyzed by immunoblotting using antibodies
against Sup35, Phb1 and Phb2. In agreement with previous results [47],
after centrifugation most of the Sup35 protein was found in the pellet
fraction in the [PSI+] strain,whereas in the [psi−] strain Sup35 remained
in the supernatant (Fig. 3, upper panel). Prohibitins were detected
almost exclusively in the pellet fraction, although some remained in the
sucrose cushion. The presence of prohibitins in the pellet cannot be
attributed to the residual presence of contaminating mitochondria, as
their absence was carefully controlled by the absence of the other
mitochondrial protein, aconitase (Aco1) in the pellet. Interestingly, both
Phb1 and Phb2 were relatively more abundant in the pellet fraction
from the [PSI+] strain than in the respective fraction from the [psi−]
strain (Fig. 3, lower panel). This suggests that prohibitins are partially
trapped by cytoplasmic [PSI+] prion aggregates, which in turn should
decrease their availability for import into the mitochondria.
3.5. [PSI+] causes premature fragmentation of mitochondria
The yeast mutants with inactive prohibitin showed abnormal
mitochondrial morphology and defects of mitochondria segregation,
especially in old cells [48]. A recent study in mammals revealed that
prohibitins determine cristae morphogenesis and formation of tubularmitochondrial ultrastructures, since 90% of PHB2-deﬁcient mouse cells
contained fragmented mitochondria [49]. We explored the possibility
that [PSI+] could indirectly affect fusion of mitochondria in yeast by
reduction of the levels of mitochondrial prohibitins. To investigate
mitochondrial ultrastructure, [psi−] and [PSI+] cells were transformed
with pYX323-mtGFP plasmid (2 µ, TRP1) encoding green ﬂuorescent
protein (GFP) containing amitochondrial localization signal. To prevent
the loss of plasmid, cells were cultivated in minimal medium lacking
tryptophan. The growth rate was controlled by OD measurements,
indicating no difference between [psi−] and [PSI+] strains. Cells were
harvested at the same point in the late logarithmic phase and examined
by confocal microscopy. Strikingly, [PSI+] cells contained 95% of
fragmented mitochondria whereas the majority of [psi−] cells in the
same phase contained regular tubular mitochondrial ultrastructures
(Fig. 4). This showedpremature fragmentationofmitochondria in [PSI+]
cells, providing a link between the presence of cytoplasmic prion [PSI+]
1708 J. Sikora et al. / Biochimica et Biophysica Acta 1793 (2009) 1703-1709and defects in mitochondrial fusion, which may be caused by reduced
prohibitins (see Discussion).
4. Discussion
Several years ago it was reported that stability of the mitochondria-
encoded respiratory chain subunit Cox2 in a mitochondrial ribosomal
mutantnam9-1 depends on the yeast prion [PSI+] [20]. This observation
is striking because the prion is located in the cytosol, whereas the
synthesis and assembly of Cox2 takes place in mitochondria. In order to
obtain a better insight into this unexpected relation, we used a pro-
teomic approach to search for differences in the levels of mitochondrial
proteins in prion-positive [PSI+] and prion-negative [psi−] cells. We
obtained a list of 44mitochondrial proteins showing altered abundance
depending on the presence of [PSI+]. Among those were Cox2 and
several other subunits of cytochromeoxidaseandmitochondrialATPase.
Importantly, the levels of the two prohibitins, Phb1 and Phb2, were also
reduced in mitochondria of [PSI+] cells.
Prohibitins are evolutionarily conserved eukaryotic proteins that
assemble in a large ring complex bound to inner mitochondrial mem-
brane [51–53]. Earlier ﬁndings in yeast identiﬁed prohibitins in
assemblies with ATP-dependent protease m-AAA involved in chaper-
oning and turnover of mitochondrial inner membrane proteins [43,44].
Yeast mutants lacking functional prohibitins show accelerated proteol-
ysis bym-AAAprotease suggesting a regulatory role of prohibitins in the
quality control of proteins in innermembrane [45,50]. Phb1/2 complex,
reminiscent of Hsp60-like chaperones, is proposed to act as a novel type
of membrane-associated chaperone/holdase involved in higher order
organization of respiratory chain complexes [51–53].
Using molecular methods provides evidence that Phb1, Phb2 and
Cox2 are less abundant in mitochondria in [PSI+] cells, thus conﬁrming
proteomic results and suggesting lowered mitochondrial prohibitins as
a potential reason of Cox2 destabilization.
Another functionof prohibitinsdescribed recently inmammals is the
processing of the dynamin-likeGTPaseOPA1, an essential component of
the mitochondrial fusion machinery [49]. OPA1 is a homologue of yeast
Mgm1 protein also involved in mitochondrial fusion [54]. Both OPA1
andMgm1 exist in forms of different lengths and their function is regu-
lated by proteolytic cleavage [55,56] Only a long formof OPA1 (L-OPA1)
is fusion competent [55], and maintenance of this form requires
prohibitins [49]. Depletion of prohibitins induces L-OPA1-dependent
fragmentation of mitochondria and apoptosis. The mechanism under-
lying the selective loss of L-OPA1 in the absence of prohibitins remains
to be elucidated [57].
Here we detected [PSI+]-dependent premature fragmentation of
yeast mitochondria in post-exponential growth phase. It is currently
unknown whether the low level of mitochondrial prohibitins in [PSI+]
cells can provide the rationale for the observed negative effect on
mitochondrial fusion. One interesting hypothesis is that depletion of
prohibitins could contribute to the defect in the function of Mgm1, the
OPA1 homologue, in the fusion of yeast mitochondria. Although Mgm1
processing is not strictly required for mitochondrial fusion [58], the
balanced formation or regulated inter-conversion of the two isoforms of
Mgm1 appear crucial [59]. Characterization of the effect of prohibitins
on Mgm1 requires further study. Among the other mitochondrial
proteins found to be affected by [PSI+] in this work, the presence of
Hsp78 is remarkable, because this chaperone functions in restoration of
the mitochondrial network following heat stress [60].
Although the overall level of expression of prohibitins is the same in
the [PSI+] and [psi−] strains, the PSI status affects their distribution
within thecell.Wewere interested inwhy themitochondrial localization
of prohibitins was reduced by the [PSI+] prion state. Fractionation of
mitochondria-free lysates for soluble and aggregate parts showed
enrichment of prohibitins in the aggregate fraction in [PSI+] cells. This
result suggests some interaction of Phb1/Phb2 with [PSI+] possibly
leading to sequestration of prohibitins by prion aggregates. The effect of[PSI+] on sequestering of another cytoplasmic protein, translation
termination factor Sup45, has been studied in the past, but the results
were controversial. Sup45 was reported to be present in [PSI+]
aggregates in some [21,61] but not other studies [62] and a decisive
model of Sup45 sequestering is lacking. Similarly, further experiments
are required to demonstrate and characterize a speciﬁc interaction of
prohibitins with [PSI+] aggregates. Here we just propose that the newly
synthesized prohibitins are titrated by [PSI+] aggregates in the cytosol
before they reach mitochondrial location and therefore their level in
mitochondria is lowered, which in turn reduces the stability of Cox2.
Moreover, we believe that prohibitins are not the only component
mediating the effect of the [PSI+] prion on mitochondrial function and
the roles of other mitochondrial proteins identiﬁed by our proteomic
study is worth to study as well.
A different scenario may be proposed of how presence of [PSI+]
aggregates interferes with mitochondrial function. Inefﬁcient termi-
nation in cells containing [PSI+] potentially allows for readthrough of
stop codons nuclear mRNAs. Leakiness of stop codons is considered to
be the reason for a variety a weak phenotypes manifested by [PSI+]
strains [10]. Nuclear-encoded mitochondrial proteins might be
expressed in a C-terminally extended version(s) when low levels of
functional Sup35 allow readthrough of nonsense codons. However, in
this and other published studies no experimental evidence of C-
terminally extended proteins in [PSI+] mitochondria has been found.
Theoverall data presentedhere support themodel that in S. cerevisiae
the prion [PSI+] interacts with prohibitins and possibly other proteins in
the cytosol and thereby alters their distribution to mitochondria. Thus
the hidden phenotypic variation generated by [PSI+] may result from
subtle alteration in sorting of particular proteins between cellular
compartments. It is possible that some of the [PSI+] manifestations can
be related to the ability of Sup35 prion aggregates to titrate host proteins
with important functions though this suggestion has never been
supported.
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